证券记录 · 已归档季度
HCA
HCA Healthcare, Inc. · Healthcare · Medical - Care Facilities
21被追踪持有人
n/aΔ持有人
27.53M持有股份
$8.84B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 66.96K | $27.12M | n/a | −2 |
| Q2 2026 | 161 | -3 | 97.44M | $37.99B | +4 | −9 |
| Q1 2026 | 169 | +3 | 106.88M | $50.54B | +5 | −3 |
| Q4 2025 | 165 | -1 | 114.61M | $53.42B | +1 | −1 |
| Q3 2025 | 26 | +1 | 64.51M | $27.48B | +1 | −1 |
| Q2 2025 | 23 | +1 | 60.26M | $23.08B | +1 | n/a |
| Q1 2025 | 19 | -2 | 30.59M | $10.56B | +1 | −3 |
| Q4 2024 | 21 | 0 | 31.21M | $9.36B | +1 | −1 |
| Q3 2024 | 20 | -1 | 22.69M | $9.21B | +1 | −2 |
| Q2 2024 | 21 | n/a | 27.53M | $8.84B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 10.78M | n/a | $3.46B | 0.6% | n/c | 1 | SEC ↗ ×9 |
| 2 | Geode Capital Management ✦ (被动) | 3.90M | n/a | $1.25B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 2.89M | n/a | $927.54M | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (被动) | 2.87M | n/a | $921.91M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 2.52M | n/a | $809.99M | 0.7% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.39M | n/a | $769.11M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 7 | Viking Global Investors ✦ | 654.17K | n/a | $210.17M | 0.8% | n/c | 1 | SEC ↗ |
| 8 | Harris Associates (Oakmark) ✦ | 372.01K | n/a | $119.52M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 295.90K | n/a | $95.07M | 0.5% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 252.72K | n/a | $81.19M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Glenview Capital ✦ | 195.59K | n/a | $62.84M | 1.3% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 142.61K | n/a | $45.82M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 71.82K | n/a | $23.07M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Citadel Advisors ✦ | 50.64K | n/a | $16.27M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | GAMCO Investors ✦ | 38.23K | n/a | $12.28M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Markel Group ✦ | 35.10K | n/a | $11.28M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 27.46K | n/a | $8.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 22.11K | n/a | $7.10M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 12.80K | n/a | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 1.60K | n/a | $514,048 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 783 | n/a | $251,815 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,403 持有人, 128.02M 股份, $58.43B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据